How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration.

Published in:

Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0281-2

By:

• Furlong, Pat;
• Bridges, John F. P.;
• Charnas, Lawrence;
• Fallon, Justin R.;
• Fischer, Ryan;
• Flanigan, Kevin M.;
• Franson, Timothy R.;
• Gulati, Neera;
• McDonald, Craig;
• Peay, Holly;
• Lee Sweeney, H.

Publication type:

Article